Telaglenastat plus cabozantinib in patients with metastatic kidney cancer
Cell metabolism in kidney cancer tumours is disrupted, and tumour [...]
Cell metabolism in kidney cancer tumours is disrupted, and tumour [...]
The results of COSMIC-131 were presented at the European Society [...]
MiT family translocation renal cell carcinoma is a rare and [...]
This recent study looked at the effects of cabozantinib on [...]
This study looked at real world data from people with [...]
Preliminary results from the COSMIC-313 clinical trial have ben released. [...]
Ongoing results from the phase 3 CheckMate-9ER clinical trial with [...]
Collecting duct carcinoma is a rare and aggressive form of [...]
This phase 1 clinical trial looked at the safety, tolerability, [...]
Results from a phase 2 study were presented at the [...]